This suggests that, although many cancer cells rely on glucose metabolism, glucose is not the only key driver of cancer growth and progression in metabolic disorders (Kang et al. 2018), in which other factors such as IGF-1 may be involved. This evidence concerns the gene IGF1 and Other metabolic disease.